Dermata Therapeutics, Inc. (DRMA) Social Stream
DERMATA THERAPEUTICS INC (DRMA) Price Targets From Analysts
Use the tables below to see what analysts covering DERMATA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 2 | $14 | $9 | $11.5 | $0.68 | 1591.18% |
| 2022-04-08 | 1 | $14 | $4 | $9 | $0.68 | 1223.53% |
| 2022-10-03 | 1 | $14.001 | $4 | $9 | $0.68 | 1223.53% |
| 2022-11-10 | 2 | $11 | $4 | $7.5 | $0.68 | 1002.94% |
| 2022-12-09 | 2 | $11 | $1 | $6 | $0.68 | 782.35% |
| 2023-03-17 | 2 | $176 | $16 | $96 | $0.68 | 14017.65% |
| 2023-03-23 | 2 | $176 | $4 | $90 | $0.68 | 13135.29% |
| 2023-04-06 | 2 | $4 | $4 | $4 | $0.68 | 488.24% |
| 2023-12-08 | 2 | $2.5 | $2.5 | $2.5 | $0.68 | 267.65% |
The Trend in the Analyst Price Target
DRMA's average price target has moved down $5 over the prior 13 months.
DRMA reports an average of 2,233.67% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 2 | 176.0 | 16.0 | 96.0 | 1.78 | 5293.26% |
| 2023-03-23 | 2 | 4.0 | 4.0 | 4.0 | 1.68 | 138.1% |
| 2023-03-23 | 2 | 176.0 | 4.0 | 90.0 | 1.68 | 5257.14% |
| 2023-04-06 | 2 | 4.0 | 4.0 | 4.0 | 1.14 | 250.88% |
| 2023-12-08 | 2 | 2.5 | 2.5 | 2.5 | 0.76 | 228.95% |
DRMA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 39 weeks, DRMA's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, DERMATA THERAPEUTICS INC's number of analysts covering the stock is greater than 22.64% of them.
- In the context of all US stocks, DERMATA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1159.73% of them.
- DRMA has a lower variance in analysts' estimates than -690.04% of all US stocks.
- In terms of how DERMATA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 291.57% of that group.
Stocks similar to DERMATA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CVKD, GDTC, and PRFX.
View All Top Stocks by Price Target
Make investment decisions regarding DRMA using the data that counts. Try POWR Ratings for free.